MedPath

CODEINE CONTIN 150MG CONTROLLED RELEASE TAB

CODEINE CONTIN 150MG CONTROLLED RELEASE TAB

Approved
DIN Number

02163780

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

purdue pharma

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02163780
AIG Number0153086002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
R05DA04 CODEINE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CODEINE (CODEINE SULFATE TRIHYDRATE, CODEINE MONOHYDRATE)Active
Strength: 150 MG
Monograph: CODEINE (CODEINE SULFATE TRIHYDRATE, CODEINE MONOHYDRATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.